AIM: To investigate spleen status in psoriasis and its relationship with hepatic steatosis, Psoriasis Area and Severity Index, and insulin resistance. METHODS: Seventy-nine psoriatic patients who were not suffering from any chronic inflammatory disease were retrospectively selected for inclusion in this study, and their complete medical records were accessed. An age- and sex-matched group of 80 non-psoriatic, obese patients was included as a control. The following relevant data were collected: age, sex, weight, height, body mass index, waist circumference, blood pressure, insulin resistance status, age at psoriasis onset, and severity of psoriasis. Abdominal ultrasonography was performed to determine spleen longitudinal diameter (SLD), and hepatic steatosis grade. RESULTS: The SLD of control obese patients was greater than that of psoriatic subjects (P = 0.013), but body mass index predicted the size of the spleen in psoriatic patients (P < 0.001). The SLD of psoriatic patients with normal weight was significantly reduced with respect to the overweight/obese psoriatic patients (P = 0.002). A multiple regression analysis revealed that body mass index was a unique predictor of the spleen size (P < 0.001). Finally, the disease duration predicted the spleen size in psoriatic subjects (P = 0.038). CONCLUSION: This study shows a correlation between the SLD and the duration of psoriasis.
AIM: To investigate spleen status in psoriasis and its relationship with hepatic steatosis, Psoriasis Area and Severity Index, and insulin resistance. METHODS: Seventy-nine psoriatic patients who were not suffering from any chronic inflammatory disease were retrospectively selected for inclusion in this study, and their complete medical records were accessed. An age- and sex-matched group of 80 non-psoriatic, obesepatients was included as a control. The following relevant data were collected: age, sex, weight, height, body mass index, waist circumference, blood pressure, insulin resistance status, age at psoriasis onset, and severity of psoriasis. Abdominal ultrasonography was performed to determine spleen longitudinal diameter (SLD), and hepatic steatosis grade. RESULTS: The SLD of control obesepatients was greater than that of psoriatic subjects (P = 0.013), but body mass index predicted the size of the spleen in psoriatic patients (P < 0.001). The SLD of psoriaticpatients with normal weight was significantly reduced with respect to the overweight/obese psoriaticpatients (P = 0.002). A multiple regression analysis revealed that body mass index was a unique predictor of the spleen size (P < 0.001). Finally, the disease duration predicted the spleen size in psoriatic subjects (P = 0.038). CONCLUSION: This study shows a correlation between the SLD and the duration of psoriasis.
Authors: K Asadullah; W Sterry; K Stephanek; D Jasulaitis; M Leupold; H Audring; H D Volk; W D Döcke Journal: J Clin Invest Date: 1998-02-15 Impact factor: 14.808
Authors: Batya B Davidovici; Naveed Sattar; Jörg C Prinz; Prinz C Jörg; Luis Puig; Paul Emery; Jonathan N Barker; Peter van de Kerkhof; Mona Ståhle; Frank O Nestle; Giampiero Girolomoni; James G Krueger Journal: J Invest Dermatol Date: 2010-05-06 Impact factor: 8.551
Authors: Anna Balato; Roberta Di Caprio; Luigi Canta; Martina Mattii; Serena Lembo; Annunziata Raimondo; Maria Schiattarella; Nicola Balato; Fabio Ayala Journal: Arch Dermatol Res Date: 2014-02-13 Impact factor: 3.017
Authors: Sidney Pestka; Christopher D Krause; Devanand Sarkar; Mark R Walter; Yufang Shi; Paul B Fisher Journal: Annu Rev Immunol Date: 2004 Impact factor: 28.527
Authors: Luigi Barrea; Paolo Emidio Macchia; Carolina Di Somma; Maddalena Napolitano; Anna Balato; Andrea Falco; Maria Cristina Savanelli; Nicola Balato; Annamaria Colao; Silvia Savastano Journal: J Transl Med Date: 2016-05-10 Impact factor: 5.531
Authors: Nikolai A Kolchak; Maria K Tetarnikova; Maria S Theodoropoulou; Alexandra P Michalopoulou; Demetrios S Theodoropoulos Journal: J Multidiscip Healthc Date: 2017-12-27